Cyanosis surgery: Difference between revisions
Line 18: | Line 18: | ||
'''AF:''' [[Atrial fibrillation]]; | '''AF:''' [[Atrial fibrillation]]; | ||
'''VF:''' [[Ventricular fibrillation]]; | '''VF:''' [[Ventricular fibrillation]]; | ||
'''PR:''' [[Pulmonary regurgitation]]; | |||
</span> | </span> | ||
<br> | <br> | ||
Line 83: | Line 84: | ||
❑ Asymptomatic moderate to severe [[ pulmonary regurgitation]] after repaired [[TOF]]<br> | ❑ Asymptomatic moderate to severe [[ pulmonary regurgitation]] after repaired [[TOF]]<br> | ||
<span style="font-size:85%;color:red"> Pulmonary stenosis valvotomy:<span style="color:red"> Surgical or balloon valvotomy in case of severe PS during infancy or childhood is recommended. Both of interventions can result pulmonary regurgitation and right ventricle dilation in the future and the need for pulmonary valve replacement.</span><br> | <span style="font-size:85%;color:red"> Pulmonary stenosis valvotomy:<span style="color:red"> Surgical or balloon valvotomy in case of severe PS during infancy or childhood is recommended. Both of interventions can result pulmonary regurgitation and right ventricle dilation in the future and the need for pulmonary valve replacement.</span><br> | ||
|- | |||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''Indication for [[Pulmonary valve replacement ]] (surgical) in [[Tetralogy of fallot]] : ([[ACC AHA guidelines classification scheme|Class 2b, Level of Evidence C]])''' | |||
|- | |||
|style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align=left| | |||
❑ Moderate to severe [[PR]] with other lesions requiring surgery in repaired [[TOF]]<br> | |||
❑ Moderate to severe [[PR]] with ventricular tachycardia requiring arrhythmia management in repaired [[TOF]]<br> | |||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''Indication for [[Tricuspid valve replacement ]] in [[CCTGA]] : ([[ACC AHA guidelines classification scheme|Class I, Level of Evidence B]])''' | |style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''Indication for [[Tricuspid valve replacement ]] in [[CCTGA]] : ([[ACC AHA guidelines classification scheme|Class I, Level of Evidence B]])''' |
Revision as of 06:40, 28 October 2020
Cyanosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Cyanosis surgery On the Web |
American Roentgen Ray Society Images of Cyanosis surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Recommendation for surgery in cyanotic heart disease
The table shows indications for surgery in cyanotic congenital heart disease according to 2018 AHA/ACC Guideline:[1]
Abbreviations:
TGA: Transposition of great arteries;
PDA: Patent ductus arteriosus ;
ASD: Atrial septal defect;
VSD: Ventricular septal defect;
TAPVC: Total anomalous pulmonary venous connection;
TOF: Tetralogy of fallot;
CCTGA: Congenitally corrected transposition of the great arteries;
PS: Pulmonary stenosis;
AF: Atrial fibrillation;
VF: Ventricular fibrillation;
PR: Pulmonary regurgitation;
Recommendation for surgery in cyanotic congenital heart disease |
Indications for repair of a scimitar vein in Anomalous pulmonary venous connection (TAPVC) (Class I, Level of Evidence B ): |
❑ Decreased functional capacity |
Indications for surgery in Anomalous Pulmonary Venous Connections (TAPVC)(Class 2a, Level of Evidence B) : |
❑ Asymptomatic adults with right ventricle volume overload |
Indications for surgical repair or reoperation in Ebstein anomaly : (Class I, Level of Evidence B) |
❑ Significant tricuspid regurgitation in the presence of the following: |
Indications for surgical repair or reoperation in Ebstein anomaly:(Class 2a, Level of Evidence B) |
❑ Significant tricuspid regurgitation in the presence of the following: |
Indication for Glenn anastomousis at the time of repair in Ebstein anomaly : (Class 2b, Level of Evidence B) |
❑ Severe right ventricle dilation |
Indication for pulmonary valve replacement ( surgical or percutaneous in Tetralogy of fallot (Class I, Level of Evidence B): |
❑ Symptomatic Moderate to severe pulmonary regurgitation after repaired TOF in which symptoms can not be explained otherwise. |
Indication for Pulmonary valve replacement ( surgical or percutaneous in Tetralogy of fallot : (Class 2a, Level of Evidence B) |
❑ Asymptomatic moderate to severe pulmonary regurgitation after repaired TOF |
Indication for Pulmonary valve replacement (surgical) in Tetralogy of fallot : (Class 2b, Level of Evidence C) |
❑ Moderate to severe PR with other lesions requiring surgery in repaired TOF |
Indication for Tricuspid valve replacement in CCTGA : (Class I, Level of Evidence B) |
❑ Symptomatic severe tricuspid regurgitaion accompanied by preserved or mildly systolic dysfunction of systemic ventricle |
Indication for Tricuspid valve replacement in CCTGA : (Class 2a, Level of Evidence C) |
❑ Asymptomatic severe tricuspid regurgitation accompanied by mildly dilated systemic ventricle |
Indication for conduit intervention/replacement in CCTGA : (Class 2b, Level of Evidence B) |
❑ Symptomatic subpulmonary left ventricle to pulmonary artery conduit dysfunction |
Indication for Balloon valvoplasty in Pulmonary stenosis : (Class I , Level of Evidence B) |
❑ In adult with moderate to severe valvular PS with symptoms of heart failure, cyanosis from intracardiac right to left shunt, exercise intolerance |
Indication for Balloon valvoplasty in Pulmonary stenosis : (Class 2a , Level of Evidence C) |
❑ Asymptomatic severe valvular PS |
Indication for Dilation and stenting in Peripheral Pulmonary stenosis : (Class 2a, Level of Evidence B) |
❑ In adult with branch and peripheral PS , pulmonary artery dilation and stenting is recommended |
- In Ebstein anomaly surgery for tricuspid valve, as well as the following, is recommended:
References
- ↑ Stout, Karen K.; Daniels, Curt J.; Aboulhosn, Jamil A.; Bozkurt, Biykem; Broberg, Craig S.; Colman, Jack M.; Crumb, Stephen R.; Dearani, Joseph A.; Fuller, Stephanie; Gurvitz, Michelle; Khairy, Paul; Landzberg, Michael J.; Saidi, Arwa; Valente, Anne Marie; Van Hare, George F. (2019). "2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines". Circulation. 139 (14). doi:10.1161/CIR.0000000000000603. ISSN 0009-7322.